Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Total 13F shares
-
89,735,826
-
Share change
-
-2,540,796
-
Total reported value
-
$4,346,616,824
-
Put/Call ratio
-
33%
-
Price per share
-
$48.45
-
Number of holders
-
262
-
Value change
-
-$100,372,482
-
Number of buys
-
136
-
Number of sells
-
105
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2022
As of 30 Sep 2022 CYTOKINETICS INC - COMMON STOCK (CYTK) had 262 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 89,735,826 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, LORD, ABBETT & CO. LLC, Polar Capital Holdings Plc, RTW INVESTMENTS, LP, PFM Health Sciences, LP, PICTET ASSET MANAGEMENT SA, and BOXER CAPITAL, LLC.
This table shows 265 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.